Eli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study

Eli Lilly's COVID-19 Treatment Candidate Will Be the First Tested in NIH's Phase 3 Study

The National Institutes of Health is starting a head-to-head trial of several antibody treatment candidates.